血小板输注对创伤患者结局的影响
该观察性研究基于多中心前瞻性创伤登记,纳入2011年5月至2019年6月直接入住参与创伤中心的全部成年创伤患者,共19,596例。入院血小板计数(中位数229 G/L [189,271])与凝血病、创伤负荷、休克及出血严重程度相关;校正模型中血小板计数每降低50 G/L,24小时全因死亡风险增加37%(OR 0.63,95%CI 0.57-0.70;p<0.001)。严重出血患者中36%在早期(6小时内)接受血小板输注,早期输注与24小时全因死亡降低相关(对比未输注或延迟输注:OR 0.52,95%CI 0.34-0.79;p<0.05)。作者认为未来需研究确定改善严重创伤结局的血小板输注剂量。
要点
- 入院血小板计数中位数229 G/L(IQR 189-271),虽多在正常范围,仍与凝血病、创伤严重程度、休克和出血强度相关。
- 校正模型中血小板计数每降低50 G/L,24小时全因死亡风险增加37%(OR 0.63,95%CI 0.57-0.70;p<0.001)。
- 严重出血(6小时内≥4单位红细胞和/或失血死亡)患者中36%在6小时内接受早期血小板输注。
- 严重出血患者早期(6小时内)血小板输注对比未输注或延迟输注,24小时全因死亡OR 0.52(95%CI 0.34-0.79;p<0.05)。
- 作者认为未来研究需确定改善严重创伤后结局的血小板输注剂量。
适用人群与场景
- 多中心前瞻性创伤登记中2011年5月至2019年6月直接入住参与创伤中心的全部成年创伤患者,共19,596例。
- 严重出血定义为6小时内输注≥4单位红细胞和/或死于失血。
诊断标准与关键阈值
- 严重出血:6小时内≥4单位红细胞和/或失血死亡。
- 早期血小板输注定义为入院后首个6小时内输注血小板。
- 入院血小板计数中位数229 G/L(IQR 189-271)。
处置流程与药物剂量
- 严重出血患者中36%在6小时内接受早期血小板输注;早期输注对比未输注或延迟输注与24小时全因死亡降低相关(OR 0.52,95%CI 0.34-0.79;p<0.05)。
- 作者认为未来研究需确定改善严重创伤后结局的血小板输注剂量。
研究设计与关键结果
- 观察性研究,基于多中心前瞻性创伤登记,纳入19,596例成年创伤患者。
- 入院血小板计数与凝血病、创伤负荷、休克和出血严重程度相关。
- 多因素logistic回归中,血小板计数每降低50 G/L,24小时全因死亡增加37%(OR 0.63,95%CI 0.57-0.70;p<0.001)。
- 严重出血患者中36%接受早期血小板输注;早期血小板输注对比未输注或延迟输注,24小时全因死亡OR 0.52(95%CI 0.34-0.79;p<0.05)。
证据类型、等级与局限
- 证据类型:观察性研究,基于多中心前瞻性创伤登记。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为入院血小板计数虽多在正常范围,仍可预测创伤出血强度与结局。
- 作者认为严重出血患者6小时内早期血小板输注与24小时全因死亡降低相关;未来研究需确定血小板输注剂量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Trauma-induced coagulopathy includes thrombocytopenia and platelet dysfunction that impact patient outcome. Nevertheless, the role of platelet transfusion remains poorly defined. The aim of the study was 1/ to evaluate the impact of early platelet transfusion on 24-h all-cause mortality and 2/ to describe platelet count at admission (PCA) and its relationship with trauma severity and outcome.
METHODS: Observational study carried out on a multicentre prospective trauma registry. All adult trauma patients directly admitted in participating trauma centres between May 2011 and June 2019 were included. Severe haemorrhage was defined as ≥ 4 red blood cell units within 6 h and/or death from exsanguination. The impact of PCA and early platelet transfusion (i.e. within the first 6 h) on 24-h all-cause mortality was assessed using uni- and multivariate logistic regression.
RESULTS: Among the 19,596 included patients, PCA (229 G/L [189,271]) was associated with coagulopathy, traumatic burden, shock and bleeding severity. In a logistic regression model, 24-h all-cause mortality increased by 37% for every 50 G/L decrease in platelet count (OR 0.63 95% CI 0.57-0.70; p < 0.001). Regarding patients with severe hemorrhage, platelets were transfused early for 36% of patients. Early platelet transfusion was associated with a decrease in 24-h all-cause mortality (versus no or late platelets): OR 0.52 (95% CI 0.34-0.79; p < 0.05).
CONCLUSIONS: PCA, although mainly in normal range, was associated with trauma severity and coagulopathy and was predictive of bleeding intensity and outcome. Early platelet transfusion within 6 h was associated with a decrease in mortality in patients with severe hemorrhage. Future studies are needed to determine which doses of platelet transfusion will improve outcomes after major trauma.
参考来源
- Hamada SR, Garrigue D, Nougue H, et al. Impact of platelet transfusion on outcomes in trauma patients. Crit Care. 2022. PMID: 35189930. doi:10.1186/s13054-022-03928-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。